Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
For its vital role in maintaining cellular activity and survival, mitochondrion is highly involved in various diseases, and several strategies to target mitochondria have been developed for specific imaging and treatment. Among these approaches, theranostic may realize both diagnosis and therapy with one integrated material, benefiting the simplification of treatment process and candidate drug evaluation. A variety of mitochondria-targeting theranostic agents have been designed based on the differential structure and composition of mitochondria, which enable more precise localization within cellular mitochondria at disease sites, facilitating the unveiling of pathological information while concurrently performing therapeutic interventions. Here, progress of mitochondria-targeting theranostic materials reported in recent years along with background information on mitochondria-targeting and therapy have been briefly summarized, determining to deliver updated status and design ideas in this field to readers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11335472 | PMC |
| http://dx.doi.org/10.1002/EXP.20230063 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Viscosity-Responsive Mitochondria-Targeting Ir(III) Probe for Inducing and Monitoring Photodynamic-Triggered Ferroptosis.
J Med Chem
August 2025
State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Colorectal cancer (CRC) is a major cause of cancer-related death, with poor outcomes at advanced stages due to metastasis and limited early detection. Photodynamic therapy (PDT), which relies on reactive oxygen species (ROS) to kill tumor cells, is promising but limited by hypoxia and short ROS diffusion distances. Here, we report Ir-EA, a novel cyclometalated Ir(III) complex with enhanced mitochondrial targeting and dual ROS generation capability, effective under both oxygen-rich and hypoxic conditions.
View Article and Find Full Text PDFMetabolic Targeting of Oxidative Phosphorylation Enhances Chemosensitivity in Triple-Negative Breast Cancer via a Synergistic Nanomedicine.
Theranostics
August 2025
Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Rehabilitation Therapy, Breast Center, Institute of Breast Health Medicine, Department of Thoracic Surgery and Institute of Thoracic Oncology, Laboratory of Mitochondrial Metabolism and Periopera
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer. There are very few targeted treatment options with satisfactory therapeutic indexes for TNBC. Although chemotherapy is the principal treatment modality for TNBC, its effectiveness is significantly compromised by low chemosensitivity in the TNBC patient population.
View Article and Find Full Text PDFAlkyl-aryl styryl-indole dyes as fluorescent imaging and theranostic probes targeting mitochondria.
Eur J Med Chem
November 2025
Leicester School of Pharmacy, De Montfort University, Leicester, UK.
The development of mitochondria-targeting fluorescent compounds with theranostic potential for tumor cells remains a topic of great interest. Inspired by previously reported delocalized lipophilic cations (DLCs) based on styryl dye framework, we introduce a series of seventeen novel styrene dyes, several of which exhibit enhanced optical properties compared to their parent compounds. Most dyes display strong Stokes shifts (104-112 nm), primarily due to the indolyl chromophore, with minimal influence from other substituents.
View Article and Find Full Text PDFAmplifying Anti-Tumor Immune Responses via Mitochondria-Targeting Near-Infrared Photodynamic Therapy.
Adv Sci (Weinh)
September 2025
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang Key Laboratory of Minimally Invasive Technique and Precision Medicine, Zhejiang University, Hangzhou, 310016, China.
Pro-inflammatory photodynamic therapy (PDT) holds immense potential to ignite robust and long-lasting systemic anti-tumor immune responses. However, the limited penetration depth of conventional ultra violet (UV)-visible irradiation and the tumor hypoxia microenvironment significantly constrain the efficacy of immune-regulatory PDT. Here, a mitochondria-targeting enhanced nanoplatform (NZ) is reported, activated by near-infrared (NIR) light-driven PDT, to address these challenges and amplify systemic anti-tumor immunity.
View Article and Find Full Text PDF"Actual" peptide properties required for nanoparticle development in precision cancer therapeutic delivery.
J Control Release
August 2025
Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, Puncak Alam 42300, Selangor, Malaysia; Particle Design Research Group, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, Puncak Alam 42300, Selangor, Mala
Functionalizing nanoparticles with peptides (3-30 amino acids) reduces premature clearance and increases colloidal stability and targeting capacity of cancer therapeutics. Glutamate/lysine-rich zwitterionic and hydrophilic/neutral peptides minimize reticuloendothelial digestion of nanomedicine through reducing particle hydrophobicity and depressing plasma anti-PEG immunoglobulin that disrupts the PEG-based particle stealth. Anionic peptides negate protein corona formation and subsequent particle aggregation in vivo enabling efficient nanoparticles biodistribution and drug targeting by facilitating their endothelial/extracellular matrix pore diffusion.
View Article and Find Full Text PDF